{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06250283",
            "orgStudyIdInfo": {
                "id": "2043372"
            },
            "secondaryIdInfos": [
                {
                    "id": "U54GM104941",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/U54GM104941"
                }
            ],
            "organization": {
                "fullName": "University of Delaware",
                "class": "OTHER"
            },
            "briefTitle": "Resveratrol for the Prevention of Bone Loss in Postmenopausal Women",
            "officialTitle": "Resveratrol for the Prevention of Bone Loss in Postmenopausal Women",
            "therapeuticArea": [
                "Orthopedics"
            ],
            "study": "resveratrol-for-the-prevention-of-bone-loss-in-postmenopausal-women"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-02",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-18",
            "studyFirstSubmitQcDate": "2024-02-07",
            "studyFirstPostDateStruct": {
                "date": "2024-02-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Delaware",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institutes of Health (NIH)",
                    "class": "NIH"
                },
                {
                    "name": "National Institute of General Medical Sciences (NIGMS)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to examine whether daily supplementation of resveratrol would improve bone health in postmenopausal women.",
            "detailedDescription": "34 women will be randomly assigned to two groups: 1) the placebo group and 2) the resveratrol group. The resveratrol group will receive 500 mg resveratrol daily for 24 weeks, and placebo group will receive placebo pills. Both groups will receive 500 mg calcium plus 400 IU vitamin D daily.\n\nBlood and urinary biomarkers of bone metabolism will be assessed at baseline and after 12 and 24 weeks intervention. Bone mineral density will be assessed using dual-energy X-ray absorptiometry at baseline and after 24 weeks."
        },
        "conditionsModule": {
            "conditions": [
                "Low Bone Mass"
            ],
            "keywords": [
                "Resveratrol",
                "Bone Health",
                "Women Health"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 34,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Resveratrol",
                    "type": "EXPERIMENTAL",
                    "description": "Dietary Supplement: Resveratrol (500 mg) + 500 mg calcium and 400 IU vitamin D3",
                    "interventionNames": [
                        "Dietary Supplement: Resveratrol"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Dietary Supplement: Placebo (500 mg) + 500 mg calcium and 400 IU vitamin D3",
                    "interventionNames": [
                        "Dietary Supplement: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Resveratrol",
                    "description": "Resveratrol (500 mg)",
                    "armGroupLabels": [
                        "Resveratrol"
                    ]
                },
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Placebo",
                    "description": "Placebo (500 mg)",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Bone biomarker",
                    "description": "25-hydroxy vitamin D3",
                    "timeFrame": "Bone marker will be assessed before and after 12 weeks and 24 weeks intervention"
                },
                {
                    "measure": "Bone biomarker",
                    "description": "Alkaline phosphatase",
                    "timeFrame": "Bone marker will be assessed before and after 12 weeks and 24 weeks intervention"
                },
                {
                    "measure": "Bone biomarker",
                    "description": "Dsteocalcin,",
                    "timeFrame": "Bone marker will be assessed before and after 12 weeks and 24 weeks intervention"
                },
                {
                    "measure": "Bone biomarker",
                    "description": "Deoxypyridinoline",
                    "timeFrame": "Bone marker will be assessed before and after 12 weeks and 24 weeks intervention"
                },
                {
                    "measure": "Bone biomarker",
                    "description": "C-terminal telopeptide type I collagen",
                    "timeFrame": "Bone marker will be assessed before and after 12 weeks and 24 weeks intervention"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Bone mineral density",
                    "description": "Lumbar spine, hip, forearm, and whole-body bone mineral density and bone mineral content",
                    "timeFrame": "Bone mineral density will be assessed before and after 24 weeks intervention"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1 to 5 years postmenopausal women with low bone mass\n\nExclusion Criteria:\n\n* Osteoporosis\n* Taking blood thinners, endocrine, or neuroactive drugs\n* Hormone therapy\n* Diagnosed: Metabolic bone disease, renal disease, kidney stones, cancer, cardiovascular disease, diabetes mellitus, respiratory disease, gastrointestinal disease, liver disease\n* Severe menopausal symptoms, serious mood alterations, sleep disturbances\n* Abnormal uterine bleeding, endometriosis, pelvic inflammatory disease\n* Endometrial polyps, and significant uterine fibroids\n* Smokers (\u2265 20 cigarettes per day)\n* BMI \\<20 and \\> 30 kg/m2\n* Intolerance or allergic reaction to resveratrol, microcrystalline cellulose, grapes, red wine, or blueberries",
            "healthyVolunteers": true,
            "sex": "FEMALE",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sheau Ching Chai, PhD, RD",
                    "role": "CONTACT",
                    "phone": "302-831-7345",
                    "email": "scchai@udel.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Sheau Ching Chai, PhD, RD",
                    "affiliation": "University of Delaware",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Delaware",
                    "status": "RECRUITING",
                    "city": "Newark",
                    "state": "Delaware",
                    "zip": "19716",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "302-831-7218",
                            "email": "ChaiResearchLab@udel.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.68372,
                        "lon": -75.74966
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077185",
                    "term": "Resveratrol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000975",
                    "term": "Antioxidants"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000010975",
                    "term": "Platelet Aggregation Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1684",
                    "name": "Resveratrol",
                    "asFound": "Vitro",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17558",
                    "name": "Vitamins",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M17550",
                    "name": "Vitamin D",
                    "relevance": "LOW"
                },
                {
                    "id": "M6003",
                    "name": "Cholecalciferol",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M4292",
                    "name": "Antioxidants",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M13865",
                    "name": "Platelet Aggregation Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T440",
                    "name": "Calciferol",
                    "relevance": "LOW"
                },
                {
                    "id": "T442",
                    "name": "Cholecalciferol",
                    "relevance": "LOW"
                },
                {
                    "id": "T479",
                    "name": "Vitamin D3",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PlAggInh",
                    "name": "Platelet Aggregation Inhibitors"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}